Senior Director, Cell Therapy WW Medical Affairs, Multiple Myeloma

About this role

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us .

Position Overview

At BMS, we are committed to the advancement of science with the drive to improve every day for the benefit of patients. To accelerate our position as leaders in cell therapy and serve patients around the world, we are committed to being at the forefront of change.

Reporting to the Executive Director, Cell Therapy Multiple Myeloma, the Senior Director, WW Medical, Multiple Myeloma Cell Therapy will represent WW Medical Affairs as a therapeutic area expert and provide strategic scientific leadership for arlo-cel, our GPRC5D CAR T currently in clinical development in multiple myeloma. This individual will be accountable for driving global launch readiness, including external communications and market shaping, internal readiness, and strategic partnership on launch activities across the matrix. The role carries forward-looking responsibility across the broader MM Cell Therapy portfolio, including lifecycle management priorities and evidence generation strategy.

The role requires depth of scientific expertise, credibility with external thought leaders, and the leadership composure to operate effectively at the intersection of WW commercialization, local Medical Affairs, and global Clinical Development. This is a high-visibility, high-impact role at a pivotal moment in the evolution of BMS's Cell Therapy franchise, demanding an individual who can balance strategic vision with flawless operational execution in a complex, matrixed environment.

Key Responsibilities

Strategic Leadership of Arlo-cel • Lead WW Medical Affairs strategy for arlo-cel, driving global launch readiness across external communications, market shaping, and internal readiness activities

• Lead cross-functional initiatives related to arlo-cel, integrating strategies across the MM portfolio where necessary

• Collaborate with local Medical Affairs teams to align on launch strategy and tactics, ensuring cohesive, market-ready action plans globally

• Drive cross-asset collaboration and knowledge sharing, fostering a unified BMS presence in multiple myeloma, including partnerships across Cell Therapy and Oncology

• Establish and cultivate relationships with key thought leaders and KOLs at major academic centers; engage cooperative groups, steering committees, and advisory boards to generate insights and shape the evolving treatment paradigm

Seamless Execution of Core Medical Affairs Deliverables • Provide strategic input to guide publication planning and execution; serve as a key reviewer on abstracts, presentations, and publications

• Develop and implement congress strategies to achieve impactful scientific presence and engagement at major meetings including COMy, EHA, and IMS

• Provide strategic input into BMS-sponsored symposia and independent medical education events to enhance scientific dialogue

• Refine the Integrated Evidence Plan (IEP) to ensure alignment with cross-functional goals; provide strategic input for evidence generation projects, including expert review and recommendations for new ISR and CRC trials as well as HEOR analyses

• Represent arlo-cel as a leading member of the WW MM Asset Indication Medical Strategy (AIMS) team to ensure the global Medical Affairs strategy and deliverables are aligned across key medical functions and markets

• Conduct comprehensive reviews of publications and update key launchpad assets, including slide decks, training sessions, and Q&A materials

• Ensure scientific excellence in medical education and effective data exchange

Provide Scientific/Medical Expertise Across the Matrix • Offer medical insights to guide clinical development plans and influence strategic decision-making for both early and late development, including knowledge sharing across assets in the BMS pipeline

• Serve as subject matter expert to cross-functional partners in multiple myeloma, providing guidance that drives scientific and commercial priorities

• Collaborate with global and local market access and marketing teams, providing expert medical content to support key initiatives

• Work collaboratively with patient advocacy to align objectives and enhance engagement

Qualifications & Experience • Advanced degree (MD, PhD, or PharmD) required; strong background in oncology/hematology, cell biology, or a related life sciences discipline preferred

• 8-10+ years of pharmaceutical industry experience required; Medical Affairs experience required; experience in multiple myeloma required; CAR-T or cell therapy experience strongly preferred

• Demonstrated launch experience; CAR-T or cell therapy launch experience is a significant differentiator

• Familiarity with clinical and translational research activities and the drug development process

• Proven track record of operating effectively within complex, matrixed WW and cross-functional organizations; demonstrated ability to influence without authority and build alignment across diverse stakeholders

• Strategic thinking: demonstrated ability to synthesize complex inputs, perform strategic assessments, and develop clearly framed ch

Similar jobs

• Director, Cell Therapy WW Medical Affairs, Multiple Myeloma and Solid Tumor Pipeline — Bristol Myers Squibb · Princeton, NJ | Madison, Giralda, NJ
• Senior Director, Global Medical Affairs, Oncology — Modernatx · Cambridge, Massachusetts | Medical Affairs
• Senior Director, Regulatory Affairs Strategy - Cell Therapy — AstraZeneca · MD, Gaithersburg | MA, Boston | Pearl- South San Francisco
• Senior Director Clinical Development, Solid Tumor — BeiGene · Remote
• Senior Director, Isatuximab Global Marketing, Multiple Myeloma — Sanofi · Cambridge, MA | Morristown, NJ
• Senior Medical Director, Clinical Development, Hematology, Nephrology, & Transplant, Cell Therapy — AstraZeneca · MA, Boston
• Senior Medical Director, Clinical Development, Hematology, Nephrology, & Transplant, Cell Therapy — AstraZeneca (Alexion) · MA, Boston
• Senior Director, Clinical Data Management, Therapeutic Area Lead, Hematology — Merck · Rahway, New Jersey, United States | COL - Cundinamarca - Bogotá (Colpatria) | CRI - Costa Rica - Costa Rica